Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Current Assets (2016 - 2025)

Historic Current Assets for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $8.4 million.

  • Arcadia Biosciences' Current Assets fell 2169.73% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year decrease of 2169.73%. This contributed to the annual value of $9.2 million for FY2024, which is 3827.14% down from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Current Assets is $8.4 million, which was down 2169.73% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Current Assets ranged from a high of $56.6 million in Q1 2021 and a low of $7.6 million during Q2 2025
  • Its 5-year average for Current Assets is $24.1 million, with a median of $23.3 million in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 13829.03% in 2021, then plummeted by 5720.64% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Current Assets (Quarter) stood at $35.4 million in 2021, then dropped by 28.23% to $25.4 million in 2022, then crashed by 41.05% to $15.0 million in 2023, then crashed by 38.27% to $9.2 million in 2024, then fell by 9.25% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $7.6 million for Q2 2025, and $8.8 million during Q1 2025.